Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel
Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel
Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel
Submitted by
admin
on April 25, 2013 - 9:25am
Source:
TheStreet.com
News Tags:
Aveo Pharmaceuticals
kidney cancer
FDA
advisory panels
tivozanib
Headline:
Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel
Do Not Allow Advertisers to Use My Personal information
